Gold W R, Queenan J T, Woody J, Sacher R A
Am J Obstet Gynecol. 1983 Aug 15;146(8):980-1. doi: 10.1016/0002-9378(83)90978-x.
Four pregnancies managed with erythrocyte membrane oral therapy because of severe Rh disease are presented. Reduction in anti-(D) production was the goal of the study. A patient was classified as having severe Rh immunization if there was a history of fetal loss due to erythroblastosis fetalis prior to 26 weeks.
